(Q37777419)

23 August 2017

1 reference

title

Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk (English)

1 reference

23 August 2017

0 references

1 reference

7

Gregory Y H Lip

1 reference

23 August 2017

2

Francisco Marín

1 reference

23 August 2017

Mariano Valdés Chávarri

series ordinal

6

object named as

Mariano Valdés

1 reference

23 August 2017

3

Vanessa Roldán

2 references

ORCID Public Data File 2021

23 August 2017

Diana Hernández-Romero

series ordinal

5

object named as

Diana Hernández-Romero

1 reference

23 August 2017

1

Angel López-Cuenca

1 reference

23 August 2017

Rocío González-Conejero

series ordinal

4

object named as

Rocío González-Conejero

1 reference

23 August 2017

language of work or name

English

0 references

publication date

4 August 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

42

1 reference

23 August 2017

issue

8

1 reference

23 August 2017

page(s)

562-575

1 reference

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Validation of Clinical Classification Schemes for Predicting Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Factors affecting the maintenance dose of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Pharmacogenetics of oral anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Hypercoagulability and haemodynamic abnormalities in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Does heart failure confer a hypercoagulable state? Virchow's triad revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Hypothesis: is soluble P-selectin a new marker of platelet activation?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

[Improvement in fibrinolytic function following anticoagulant treatment in chronic rheumatic atrial fibrillation]

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Anticoagulation with warfarin downregulates inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Platelets and atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Atrial endocardial changes in mitral valve disease: a scanning electron microscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Fibrinogen and risk of cardiovascular disease. The Framingham Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Fibrinogen: its role in the hemostatic regulation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Blood coagulation factor XIII: structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Transglutaminases in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: implications for the prothrombotic state and stroke risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Coagulation factors II, V, VII, and X, prothrombin gene 20210G-->A transition, and factor V Leiden in coronary artery disease: high factor V clotting activity is an independent risk factor for myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

World distribution of factor V Leiden

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Functional characterization of the human factor VII 5'-flanking region

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Association of polymorphisms of platelet membrane integrins alpha IIb(beta)3 (HPA-1b/Pl) and alpha2(beta)1 (alpha807TT) with premature myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Cerebrovascular events in patients with significant stenosis of the carotid artery are associated with hyperhomocysteinemia and platelet antigen-1 (Leu33Pro) polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Collagen platelet receptor polymorphisms integrin alpha2beta1 C807T and GPVI Q317L and risk of ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Organization of the human annexin V (ANX5) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of ischemic stroke in Polish subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

An association of 5,10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Pharmacogenetics and future drug development and delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Pharmacogenetics and the practice of medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Warfarin dose adjustments based on CYP2C9 genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

CYP2C9 genotypes and dose requirements during the induction phase of oral anticoagulant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

CYP4F2 genetic variant alters required warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

A genome-wide association study of acenocoumarol maintenance dosage.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

The genetic interaction between VKORC1 c1173t and calumenin a29809g modulates the anticoagulant response of acenocoumarol.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Performance of commercial platforms for rapid genotyping of polymorphisms affecting warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Genetic determinants of response to warfarin during initial anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Estimation of the warfarin dose with clinical and pharmacogenetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

The largest prospective warfarin-treated cohort supports genetic forecasting

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Hemostatic state and atrial fibrillation (The Framingham Offspring Study)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

Flow cytometric analysis of platelet activation by different collagen types present in the vessel wall

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890.2010.507601

10.3109/07853890.2010.507601

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference